RxDoctor Payments Data

Vy Nguyen

Family · Houston, TXNPI 1851925291

Payments from drug & device makers

$9,219in general payments, 2019–2025

Across 583 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Tris Pharma Inc$787
  • AstraZeneca$777
  • Lilly USA, LLC$632
  • Novo Nordisk$629
  • Abiomed$493
  • plus $5K from 43 others

What the payments were for

  • Food & beverage$9,197100%
  • Education$220%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,219 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium13$181
Losartan Potassium12$60
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$45
Tamsulosin Hcl13$42
Rosuvastatin Calcium11$28
Azithromycin12$23
Metformin Hcl12$6
Amlodipine Besylate11$4

Paid to pharmacies, not to this prescriber.

Other family in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →